期刊文献+

糖化血红蛋白诊断糖尿病的切点研究 被引量:6

Hemoglobin Alc Cut Points for the Diagnosis of Diabetes Mellitus
暂未订购
导出
摘要 目的探讨糖化血红蛋白(HbAlc)用于诊断糖尿病的切点。方法对为明确DM诊断而初次就诊的高危人群739例进行口服葡萄糖耐量试验(OGTT),测定其空腹血糖(FPG)和服用75g葡萄糖2h后血糖(2hPG),同时测定HbAlc,根据WHO(1999年)糖代谢状态分类标准进行分组,研究人群糖耐量正常(NGT)61例,空腹血糖受损(IFG)46例,糖耐量减低(IGT)84例,糖调节受损(IGR)130例,糖尿病(DM)548例,通过受试者工作特征曲线(ROC曲线)分析,确定HbAlc用于诊断糖尿病的切点。结果NGT组的HbAlc为(5.7±0.6)%,DM组为(9.8±3.0)%,两者比较差异有统计学意义(t=10.7,P〈0.01);如以FPG≥7.0mmol/L,或以2hPG≥11.1mmol/L,或以FPG≥7.0mmol/L且2hPG≥11.1mmol/L,或以FPG≥7.0mmol/L或2hPG≥11.1mmol/L作为诊断糖尿病的标准,HbAlc切点均为6.5%,曲线下面积(AUC)分别为0.981,0.980,0.990和0.973。结论高危人群糖尿病诊断的HbAlc切点为6.5%,HbAlc不适用于糖调节受损的诊断。 Objective To investigate hemoglobin Alc(HbAlc) cut points for the diagnosis of diabetes mellitus. Methods A total of 739 high-risk peoples were selected. All had fasting plasma glucose (FPG) and post 2h plasma glucose(2h PG) measurements after a 75 g load, HbAlc was examined at same time. According to World Health Organization [WHO] (1999) criteria,61 were normal glucose tolerance(NGT) ,46 had impaired fasting glucose (IFG) ,84 had impaired glucose tolerance (IGT), 130 had impaired glucose regulation (IGR), 548 patients had diabetes mellitus (DM). Based on receiver operating characteristic curves,determine HbAlc cut points for the diagnosis of diabetes mellitus. Results The MeandzSD values of H bAIC in DM (9.8 ±3.0 %) was significantly greater than that in NGT (5.7%±0. 6 %), (t= 10.7, P〈0. 01). To identify diabetes based on four different criteria,the HbAlc cut point all were 6.5% ,and the areas under the curve (AUC) were 0. 981,0. 981,0. 991 and 0. 973,respectively. Conclusion The HbAlc cut point was 6.5% for the diagnosis of diabetes mellitus,but can't apply to the diagnosis of IGR.
出处 《现代检验医学杂志》 CAS 2012年第3期69-73,共5页 Journal of Modern Laboratory Medicine
关键词 糖化血红蛋白 糖尿病 糖调节受损 葡萄糖耐量试验 hemoglobin Alc diabetes mellitus impaired glucose regulation oral glucose tolerance test
  • 相关文献

参考文献16

二级参考文献97

  • 1周翔海,纪立农.空腹血糖和糖化血红蛋白用于筛查糖尿病的研究[J].中华糖尿病杂志(1006-6187),2005,13(3):203-205. 被引量:158
  • 2梁红峰.空腹血糖和糖化血红蛋白用于筛查早期糖尿病的比较研究[J].国际医药卫生导报,2007,13(13):79-82. 被引量:11
  • 3The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.Report of the expert committee on the diagnosis and classification of diabetes mellitus.Diabetes Care,1997,20:1183-1197.
  • 4World Health Organization.Definition,diagnosis and classification of diabetes mellitus and its complications:Report of a WHO consultation.Part 1.Diagnosis and classification of diabetes Mellitus.Geneva,World Health Org,1999.
  • 5Ealovega MW,Tabaei BP,Brandle M,et al.Opportunistic screening for diabetes in routine clinical practice.Diabetes Care,2004,27:9-12.
  • 6Mooy JM,Grootenhuis PA,de Vries H,et al.Intra-individual variation of glucose,specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population:the Hoorn Study.Diabetologia,1996,39:298-305.
  • 7Perry RC,Shankar RR,Fineberg N,et al.Early diabetes intervention program (EDIP):HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose:the Early Diabetes Intervention Program (EDIP).Diabetes Care,2001,24:465-471.
  • 8Rohlfing C,Wiedmeyer HM,Little R,et al.Biological variation of glycohemoglobin.Clin Chem,2002,48:1116-1118.
  • 9Little RR,Rohlfing CL,Tennill AL,et al.Effects of sample storage conditions on glycated hemoglobin measurement:evaluation of five different high performance liquid chromatography methods.Diabetes Technology and Therapeutics,2007,9:36-42.
  • 10Little R.Glycated hemoglobin standardization-National glycohemoglobin standardization program (NGSP) perspective.Clin Chem Lab Med,2003,41:1191-1198.

共引文献307

同被引文献49

  • 1孟作龙,李坤山,方莹,周颖,赵艳,韩月香,王晓敏.糖化血红蛋白与糖调节受损血糖水平相关性的研究[J].中华糖尿病杂志,2010,2(1). 被引量:7
  • 2杨有业,张秀明.临床检验方法学评价[M].北京:人民卫生出版社,2008:118-127.
  • 3UK Prospective Diabetes Study (UKPDS) Group. In- tensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)[J]. Lancet,1998,352(9131) :837-853.
  • 4Ealovega MW, Tabaei BP, Brandle M, et al. Oppor- tunistic screening for diabetes in routine clinical prae- tice[J]. Diabetes Care,2004,27(1) :9-12.
  • 5Weykamp C, John WG, Mosea A. A review of the challenge in measuring hemoglobin Alc[J]. J Diabetes Sci Technol,2009,3(3) :439-445.
  • 6American Diabetes Association. Standards of medical care in diabetesd 2012 [J]. Diabetes Care, 2012, 35 (Suppl 1) : S11-S63.
  • 7Albreviated Report of a WHO Consultation. Use of glycated hemoglobin(HbAlc) in the diagnosis of dia- betes mellitus[S]. Geneva : WHO, 2011: 1-25.
  • 8Bao YQ, Ma X,Li H, et al. Glycated haemoglobin Ale for diagnosing diabetes in Chinese population: cross sectional epidemiological survey [J]. BMJ, 2010, 10 (340) : 2249-2256.
  • 9Nathan DM,Kuenen J,Borg R,et al. Alc-DerivedAv- erageGlueose Study Group. Translating the Ale as- say into estimated average glucose values[J]. Diabetes Care,2008,31(8):1473-1478.
  • 10Consensus Committee. Consensus statement on the worldwide standardization of the hemoglobin Alc measurement: the Amerrican diabetes association, european association for the study of diabetes,inter- national federation of clinical chemistry and labora- tory medicine and the international diabetes federa- tion[J]. Clin Chem, 2007,30 (9): 2399-2400.

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部